AnaptysBio Competitors and Similar CompaniesClear all
GlycoMimetics's competitors and similar companies include Verastem Oncology and Spectrum Pharmaceuticals.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Spectrum Pharmaceuticals Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology. | |
Founding Date | Founding Date 2003 | Founding Date 2010 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Rockville, US HQ | Locations Needham, US HQ Walsrode, DE | Locations Henderson, US HQ Irvine, US |
Employees | Employees 5025% increase | Employees 7328% increase | Employees 14638% decrease |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) 144.9 m | Valuation ($) 211.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) $10.1m (FY, 2022) |
Net income | Net income ($153.9m) (FY, 2025) | Net income ($209.5m) (FY, 2025) | Net income ($75.4m) (FY, 2022) |
Operating ⚠ | |||
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 4 (FY, 2020) | Phase II Trials Products 1 (FY, 2016) |
Funding | |||
Total funding raised | Total funding raised $ 101.8m | Total funding raised $ 170m | Total funding raised $ 3m |
For sources of this data, please see the company profile
View Company Profiles
Verastem Oncology
HQ
Needham, US
Employees
73↑ 28% increase
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View companySpectrum Pharmaceuticals
HQ
Henderson, US
Employees
146↓ 38% decrease
Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.
View company